Using a subcutaneous catheter for ovarian stimulation in IVF
Use of a Subcutaneous Catheter for Controlled Ovarian Stimulation
This study is testing a new catheter that delivers medication for ovarian stimulation during IVF to see if it makes the process easier and more comfortable for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Sponsor | University of Southern California Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT05505474 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the feasibility of using the Neria Guard™ subcutaneous catheter for administering medications during controlled ovarian stimulation for in-vitro fertilization (IVF). Traditional daily or twice-daily injections can be burdensome for patients, and this study aims to reduce that burden by assessing the catheter's effectiveness and safety. Primary outcomes include monitoring safety, patient satisfaction, and IVF outcomes such as oocyte yield and pregnancy rates. The study will closely track hormone levels to ensure proper medication delivery.
Who should consider this trial
Good fit: Ideal candidates are females aged 18 to 45 who are undergoing controlled ovarian stimulation for IVF.
Not a fit: Patients outside the age range of 18 to 45 or those not undergoing IVF may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the physical and emotional burden of daily injections for women undergoing IVF.
How similar studies have performed: While the use of subcutaneous catheters for medication administration has been successful in other contexts, this specific application in IVF is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female between 18 and 45 years of age undergoing controlled ovarian stimulation Exclusion Criteria: * none
Where this trial is running
Los Angeles, California
- HRC Fertility — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: Richard J Paulson, MD — University of Southern California
- Study coordinator: Rachel S Mandelbaum, MD
- Email: rachel.mandelbaum@med.usc.edu
- Phone: 6264409161
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.